Tag: Prescription Drugs
Occurrence of Cardiovascular Events, Death Compared Between Thiazides
Occurrence of major cardiovascular events, non-cancer-related deaths no lower with chlorthalidone versus hydrochlorothiazide
Progression-Free Survival Increased With Zanubrutinib in Leukemia
Longer progression-free survival seen with zanubrutinib versus ibrutinib for patients with relapsed or refractory chronic or small lymphocytic leukemia
Congressional Report Slams FDA, Drugmaker Over Approval of Alzheimer Drug Aduhelm
Controversy over Aduhelm stretches back to its June 2021 approval by the U.S. Food and Drug Administration
Molnupiravir Does Not Reduce COVID-19-Related Hospitalization, Death
No reduction in COVID-19-associated hospitalizations or deaths seen among high-risk, vaccinated adults
5α-Reductase Inhibitors Linked to Depression, but Not Dementia
Magnitude of association for finasteride and dutasteride with dementia decreased over time and became nonsignificant
Weekly Dupilumab Beneficial in Eosinophilic Esophagitis
More patients receiving dupilumab have histologic remission, improvement in Dysphagia Symptom Questionnaire scores
FDA Approves Gene Therapy for Tough-to-Treat Bladder Cancer
About 57,000 men and 18,000 women are diagnosed with bladder cancer annually
Metformin Use Linked to Lower Risk for Joint Replacement in T2DM
Reduced risk seen for total knee replacement and total hip replacement with metformin use
ASH: Glofitamab Aids Relapsed, Refractory Diffuse Large B-Cell Lymphoma
39 percent of patients had a complete response, with median time to complete response of 42 days
Sublingual Buprenorphine/Naloxone Tied to More Adverse Dental Outcomes
More adverse dental outcomes seen with sublingual buprenorphine/naloxone compared with use of transdermal buprenorphine or oral naltrexone
